Literature DB >> 374280

[Erythromycin determination in organ tissues (author's transl)].

G A Dette, U Finke.   

Abstract

The recovery rates of erythromycin after in vitro and in vivo administration were studied comparatively in liver, lung, and kidney. Using buffer standards the recovery rate in homogenates of in vitro administered erythromycin decreased with increasing protein concentration. At constant protein concentration the erythromycin administered recovered correlated linearly. Mincing the tissues with scissors was not found to be adequate, even when followed by a diffusion period of up to 24 hours. Similarly, shock freezing resulted in lower values. Even and optimal breaking down of tissues was found after homogenisation or ultrasonics. The recovery rates were not raised by treating the tissue with trypsin. There was no evidence of enzymatical erythromycin degradation in liver homogenates under the assay conditions.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 374280     DOI: 10.1007/bf01641124

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  5 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Tissue penetration of antibiotics; an overview.

Authors:  L D Sabath
Journal:  Scand J Infect Dis Suppl       Date:  1978

3.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

4.  Determination of erythromycin in pharmaceutical preparations by direct densitometry after TLC.

Authors:  C Radecka; W L Wilson; D W Hughes
Journal:  J Pharm Sci       Date:  1972-03       Impact factor: 3.534

5.  Demethylation of erythromycins by rabbit tissues in vitro.

Authors:  J C Mao; P L Tardrew
Journal:  Biochem Pharmacol       Date:  1965-07       Impact factor: 5.858

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.